448 related articles for article (PubMed ID: 16600442)
21. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
Baysal B; Tosun S; Ozdemir M; Doğan M
Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of inactivated tissue culture rabies vaccine in dogs.
Strating A; Bunn TO; Goff MT; Phillips CE
J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
Muhamuda K; Madhusudana SN; Ravi V
Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
[TBL] [Abstract][Full Text] [Related]
25. Oral vaccination of dogs with recombinant rabies virus vaccines.
Rupprecht CE; Hanlon CA; Blanton J; Manangan J; Morrill P; Murphy S; Niezgoda M; Orciari LA; Schumacher CL; Dietzschold B
Virus Res; 2005 Jul; 111(1):101-5. PubMed ID: 15896409
[TBL] [Abstract][Full Text] [Related]
26. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
[TBL] [Abstract][Full Text] [Related]
27. [The effectiveness and safety of an immunization against parvovirus and rabies in anesthetized puppies].
Mayr B; Hönig A; Gutbrod F; Wiedemann C
Tierarztl Prax; 1990 Apr; 18(2):165-9. PubMed ID: 2161572
[TBL] [Abstract][Full Text] [Related]
28. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog.
Cliquet F; Guiot AL; Schumacher C; Maki J; Cael N; Barrat J
Dev Biol (Basel); 2008; 131():257-64. PubMed ID: 18634487
[TBL] [Abstract][Full Text] [Related]
30. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
31. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
32. Human rabies immunoprophylaxis using HDC (MRC-5) vaccine.
Cox JH; Klietmann W; Schneider LG
Dev Biol Stand; 1978; 40():105-8. PubMed ID: 680382
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing the antibody response to vaccination against rabies.
Jakel V; König M; Cussler K; Hanschmann K; Thiel HJ
Dev Biol (Basel); 2008; 131():431-7. PubMed ID: 18634505
[TBL] [Abstract][Full Text] [Related]
34. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs.
Cliquet F; Gurbuxani JP; Pradhan HK; Pattnaik B; Patil SS; Regnault A; Begouen H; Guiot AL; Sood R; Mahl P; Singh R; Meslin FX; Picard E; Aubert MF; Barrat J
Vaccine; 2007 Apr; 25(17):3409-18. PubMed ID: 17224221
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
[TBL] [Abstract][Full Text] [Related]
36. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
37. Sero-prevalence of virus neutralizing antibodies for rabies in different groups of dogs following vaccination.
Pimburage RMS; Gunatilake M; Wimalaratne O; Balasuriya A; Perera KADN
BMC Vet Res; 2017 May; 13(1):133. PubMed ID: 28521804
[TBL] [Abstract][Full Text] [Related]
38. Ten year longitudinal study of efficacy and safety of purified chick embryo cell vaccine for pre- and post-exposure prophylaxis of rabies in Indian population.
Sehgal S; Bhattacharya D; Bhardwaj M
J Commun Dis; 1995 Mar; 27(1):36-43. PubMed ID: 7636151
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of the oral rabies vaccine SAG2 in raccoon dogs.
Cliquet F; Guiot AL; Munier M; Bailly J; Rupprecht CE; Barrat J
Vaccine; 2006 May; 24(20):4386-92. PubMed ID: 16603277
[TBL] [Abstract][Full Text] [Related]
40. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
Moore SM; Ricke TA; Davis RD; Briggs DJ
Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
